[{"arm_notes": "", "treatment_id": null, "treatment_name": "The study will be conducted at COVID-19 residential treatment center; District Hospital Kandana from 5th July 2021.All eligible patients will be included in the trial. 190 Participants will be randomized to each arm; \u201cexperimental arm\u201d and \u201cno intervention arm\u201d stratified for age (< 60 years or ? 60 years) and sex (male or female). Randomisation will be done using random sequence generation in block (4 in a block) randomisation with a 1:1 ratio. Patients will receive beclomethasone or the placebo in addition to usual care.Experimental arm: Beclomethasone; 600 mcg (one 400 mcg and one 200 mcg capsule); via dry powder inhaler; twice a day for 14 days or until primary outcome is achieved or discharged from the facility.No intervention arm: Placebo 2 capsules ( 25 mg lactulose each) via dry powder inhaler; twice a day for 14 days or until primary outcome is achieved (in matching capsules) or discharged from the facility.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 189, "treatment_name": "Beclomethasone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]